200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 20404-06-2
20404-06-2 | Methanediazonium (8CI,9CI)
CAS No: 20404-06-2 Catalog No: AG00299Z MDL No:
Product Description
Catalog Number:
AG00299Z
Chemical Name:
Methanediazonium (8CI,9CI)
CAS Number:
20404-06-2
Molecular Formula:
CH3N2+
Molecular Weight:
43.0479
IUPAC Name:
methanediazonium
InChI:
InChI=1S/CH3N2/c1-3-2/h1H3/q+1
InChI Key:
RRJZCACJJKZDNV-UHFFFAOYSA-N
SMILES:
C[N+]#N
Properties
Complexity:
29.3
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
43.03g/mol
Formal Charge:
1
Heavy Atom Count:
3
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
43.049g/mol
Monoisotopic Mass:
43.03g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
28.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9
Literature
| Title | Journal |
|---|---|
| Stereospecific intramolecular C-H amination of 1-aza-2-azoniaallene salts. | Journal of the American Chemical Society 20120620 |
| Synthesis of [1,2,4]-triazolo-annulated 3-aza-A-homocholestanes--a novel class of pentacyclic compounds. | Steroids 20120401 |
| In vitro and in vivo biodistribution of ZRS1, a stabilized type I N-acetoxymethyl carbamate-containing combi-molecule. | Drug metabolism letters 20110401 |
| Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. | Journal of biomedicine & biotechnology 20110101 |
| Evaluation of the exposure equivalence of oral versus intravenous temozolomide. | Cancer chemotherapy and pharmacology 20100301 |
| Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma. | Environmental health : a global access science source 20090101 |
| Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas. | Core evidence 20090101 |
| Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations. | Cancer management and research 20090101 |
| Triazene compounds: mechanism of action and related DNA repair systems. | Pharmacological research 20071001 |
| Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias. | Leukemia research 20050601 |
| Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line. | British journal of cancer 20040913 |
| The combi-targetinG concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting 'combi-triazene' SMA41. | Biochemical pharmacology 20040315 |
| Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a novel tumor targeting concept. | Journal of medicinal chemistry 20031204 |
| Metabolic activation of temozolomide measured in vivo using positron emission tomography. | Cancer research 20030515 |
| Genotoxic methylating agents modulate extracellular signal regulated kinase activity through MEK-dependent, glutathione-, and DNA methylation-independent mechanisms in lung epithelial cells. | Chemical research in toxicology 20030101 |
| Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs. | Journal of medicinal chemistry 20021205 |
| Theoretical studies on cycloaddition reactions between 1-aza-2-azoniaallene cation and olefins. | The Journal of organic chemistry 20021018 |
| Ab initio GB study of methylation reaction of adenine, cytosine, guanine, and thymine by methanediazonium ion. | Journal of theoretical biology 20020307 |
| Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy. | The Journal of pharmacology and experimental therapeutics 20010301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.